2/9/2021NMPA Adds 72 Designated Core Laboratories to Support MedPharm Regulati...

2/9/2021Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for ...

2/9/2021Lee's Pharma Announces Breakthrough Therapy Designation of Sorrento's ...

2/9/2021Betta Pharma Mulls US$800M Hong Kong IPO in the First Half

2/9/2021NDA for Amarin's VASCEPA (icosapent ethyl) Accepted in China

2/9/2021Chance Pharma In-Licenses Drug-Device Combo AER-901 from Aerami Ther...

2/9/2021Drug Farm Closes $56M Financing to Advance Lead Hepatitis B Drug into ...

2/9/2021CDE Issues the Technical Guidelines for Clinical Trial of Human Immuno...

2/9/2021SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...

2/8/2021Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak

2/8/2021Bayer Receives Approval for Nubeqa in China for the Treatment of Men ...

2/8/2021Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...

2/8/2021BMS Granted Priority Review for NDA of Luspatercept in China

2/8/2021IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...

2/5/2021JBM Healthcare Debuts IPO on the Main Board of HKSE

2/5/2021CMS Acquires Dermatology Specialty Firm Luqa

2/5/2021NMPA Holds National Drug Registration and Post Marketing Regulation Co...

2/4/2021Local Drugmakers Dominated China's 4th Round of National VBP Again, As...

2/4/2021CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...

2/4/2021Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...

2/4/2021Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline

2/3/2021Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...

2/3/2021Amgen/Celgene's NDA for Apremilast Accepted in China

2/3/2021MNCs Secure Multiple New Drug Approvals in China

2/3/2021AJMC: China Pulls Out Stops for Biosimilar Development

2/2/2021More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...

2/2/2021Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...

2/2/2021Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)

2/2/2021WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...

2/2/2021Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...

Page:97/357 Total number of articles:10684: [First][<<] [95] [96] [97] [98] [99] [>>] [End]